SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as CEO Ryan Cohen significantly increased his stake with a substantial open-market share purchase, a move echoed by another board member. This has sparked intense discussion among the community, with many viewing it as a strong bullish signal and potential catalyst for a major upward movement, while others remain cautious given prior market behavior.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC the metals company Inc. is experiencing significant investor attention following recent U.S. regulatory advancements, including modernized deep-sea mining permits and an upcoming Congressional hearing featuring its CEO. The community is highly optimistic, interpreting these moves as strong government alignment to expedite critical mineral recovery for national security, anticipating substantial upside for the company.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending after securing a significant licensing deal with Pfizer for its Matrix-M adjuvant, marking a key validation of its vaccine platform. This news is igniting widespread community discussion and strong bullish sentiment for a potential short squeeze, given the substantial short interest. Many investors view this partnership as a crucial step towards further collaborations and a re-evaluation of the company's long-term value.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing a notable surge, primarily fueled by promising 5-year clinical data for its personalized cancer vaccine in collaboration with Merck and recent global regulatory submissions for its seasonal flu vaccine. The community is actively discussing the company's improved financial outlook and strategic shift towards its diverse mRNA pipeline beyond prior vaccine products. This reevaluation is amplified by a significant short interest, with many anticipating continued momentum in the broader biotech sector.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is actively trending amid ongoing discussions surrounding Greenland's vast critical mineral rights, driven by recent statements about a potential framework agreement involving the US and NATO. The community is highly bullish, anticipating significant investment or access to Greenland's rare earth deposits, viewing recent price fluctuations as market manipulation to acquire shares before an upcoming company business update. This development is seen as crucial for bolstering Western supply chains and reducing dependence on other nations for critical minerals.

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

PAVmed Inc

PAVmed is trending following news that its subsidiary, Lucid Diagnostics, has secured a significant contract with the U.S. Department of Veterans Affairs for its EsoGuard Esophageal DNA Test, broadening access to precancer screening. This development, combined with the stock's low float, is fueling intense community discussion about a potential short squeeze and substantial upside, although some express concerns about possible dilution.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is experiencing significant market attention following recent Saudi FDA approval for its Anktiva lung cancer treatment and ongoing dialogue with the FDA for a bladder cancer resubmission. The community is intensely focused on the escalating cost to borrow and diminishing share availability, widely anticipating a massive short squeeze that could propel the stock higher. Many investors are actively "loading the boat," confident in the company's cancer immunotherapy advancements and viewing current market dynamics as a temporary battle against "trapped" short sellers.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is seeing significant activity as President Trump's announcement of a Greenland "framework" and the suspension of EU tariffs fueled a rapid market rebound. Traders are actively discussing the "TACO trade," where initial geopolitical uncertainty quickly reversed, leaving bears burned and reinforcing the "buy the dip" strategy amidst perceived market manipulation. This volatility underscores how headline-driven events continue to create dramatic swings in market sentiment.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is experiencing an extraordinary rally, driven by analyst upgrades and surging demand for memory and data storage in the AI infrastructure sector, notably influenced by Nvidia's new chip requirements. This rapid ascent has ignited fierce debate within the community, with many celebrating its "unstoppable" momentum while an equally vocal segment warns of an unsustainable "bubble" and impending correction.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is trending due to a significant partnership with Primary Digital Infrastructure for a massive AI data center campus in West Texas, coupled with a key acquisition. The community is actively discussing strong price action and anticipating an imminent announcement regarding a hyperscaler tenant, fueling speculation of continued upward momentum and a potential short squeeze within the burgeoning AI infrastructure sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Massachusetts Financial Services Co. MA Buys 202,103 Shares of Ligand Pharmaceuticals Incorporated $LGND

Massachusetts Financial Services Co. MA lifted its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 59.5% in the third quarter, according to its most recent...

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Recommendation of "Moderate Buy" by Analysts

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the company...

Stephens Investment Management Group LLC Sells 50,271 Shares of Ligand Pharmaceuticals Incorporated $LGND

Stephens Investment Management Group LLC lessened its stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 8.3% in the 3rd quarter, according to the company in its...

SG Americas Securities LLC Has $2.08 Million Stock Position in Ligand Pharmaceuticals Incorporated $LGND

SG Americas Securities LLC boosted its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 280.0% in the 3rd quarter, according to its most recent disclosure with...

John Kozarich Sells 467 Shares of Ligand Pharmaceuticals (NASDAQ:LGND) Stock

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) Director John Kozarich sold 467 shares of the business's stock in a transaction dated Friday, January 2nd. The shares were sold at...

Insider Selling: Ligand Pharmaceuticals (NASDAQ:LGND) Director Sells 467 Shares of Stock

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) Director John Kozarich sold 467 shares of the business's stock in a transaction that occurred on Friday, January 2nd. The stock was...

Allspring Global Investments Holdings LLC Buys 32,379 Shares of Ligand Pharmaceuticals Incorporated $LGND

Allspring Global Investments Holdings LLC boosted its stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 42.6% in the third quarter, according to its most recent Form 13F...

Moody Aldrich Partners LLC Buys Shares of 25,884 Ligand Pharmaceuticals Incorporated $LGND

Moody Aldrich Partners LLC bought a new position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F...

Calamos Advisors LLC Grows Stake in Ligand Pharmaceuticals Incorporated $LGND

Calamos Advisors LLC lifted its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 69.8% during the 3rd quarter, according to the company in its most recent Form 13F...

Ligand Pharmaceuticals Incorporated $LGND Position Trimmed by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC trimmed its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 12.7% in the 3rd quarter, according to its most recent disclosure...

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Current Price	$199.51
Prev Close	$196.56
Open	$197.82
Dividend Yield	0.00%
50-Day Moving Average	$197.17
Beta	1.00
Avg. Volume	207,856.45
PE Ratio	94.61

52-Week High	$212.49
52-Week Low	$93.58
Market Capitalization	$3.87B
EPS (Annual)	-$0.2204
Price to Book	4.07
Revenue Per Employee	$2.46M
Enterprise Value/EBITDA	N/A

LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LGND News

LGNDLigand Pharmaceuticals, Inc. - Ordinary Shares - Class B